Gendre, J P <br/><br/>
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)  [electronic resource] 

 -  Gastroenterology  Feb 1993 
 - 435-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0016-5085 
<br/><br/><label>Standard No.: </label>10.1016/0016-5085(93)90411-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aminosalicylic Acids--adverse effects<br/>Crohn Disease--drug therapy<br/>Delayed-Action Preparations--adverse effects<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Mesalamine<br/>Middle Aged<br/>Patient Compliance<br/>Treatment Outcome